Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of World Acceptance Corporation (WRLD) and Encourages WRLD Investors to Contact the Firm
NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of World Acceptance Corporation (NASDAQ: WRLD).
Click here to participate in the action.
On June 14, 2017, post-market, World Acceptance revealed that it would delay the filing of its annual report on Form 10-K with the U.S. Securities and Exchange Commission (“SEC”), citing an internal probe of its Mexico operations. Commissioned in March, the investigation focuses on the legality under the U.S. Foreign Corrupt Practices Act and local laws of certain payments related to loans, maintenance of books and records, and treatment of compensation matters for certain employees. On this news, the company’s share price fell by more than 12%, closing at $73.00 on June 15, 2017.
On August 8, 2017, post-market, the company disclosed that the SEC had “issued a formal order of investigation” in connection with its internal probe of its Mexico operations. On this news, World Acceptance’s share price fell $1.74, or 2.16%, to close at $78.68 on August 9, 2017.
If you are a long term stockholder of World Acceptance, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into World Acceptance please go to https://bespc.com/wrld/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.